Salarius Pharmaceuticals ...

1.06
0.04 (3.41%)
At close: Mar 05, 2025, 12:54 PM

Salarius Pharmaceuticals Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Net Income -12.54M -31.61M -12.77M -7.35M -6.94M -21.92M -34.43M -39.49M -29.14M n/a
Depreciation & Amortization 10.05K 6.68K 19.18K 18.06K 127.41K 228.16K 324.55K 277.23K 49.88K n/a
Stock-Based Compensation 524.84K 796.8K 559.04K 319.39K 751.62K 1.94M 4.22M 6.57M 6.6M n/a
Other Working Capital -193.35K 1.06M 2.35M -3.04M -3.69M -2.45M 1.39M 728.34K 1.11M n/a
Other Non-Cash Items 130K 10.84M -44.69K -258.55K -1.31M 20.31K 1.78K 3.43K 4.12K n/a
Deferred Income Tax n/a n/a n/a n/a n/a 11.54K -68.14K 16.16K 9.52K n/a
Change in Working Capital -968.33K 2.37M 2.03M -3.04M -4.21M -3.88M 2.23M 571.46K 1.73M n/a
Operating Cash Flow -12.85M -17.6M -10.2M -10.31M -11.58M -23.6M -27.72M -32.05M -20.75M n/a
Capital Expenditures -3 -1.5M n/a -2.6K n/a n/a -113.5K -559.38K -265.62K n/a
Acquisitions n/a n/a n/a n/a 5.61M n/a 5.34K 5.25K n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a -2M -32.99M -38.68M -39.4M n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a 16.12M 57.59M 27M 12.4M n/a
Other Investing Acitivies n/a -1.5M n/a n/a 204.27K 4.8K 5.34K 5.25K n/a n/a
Investing Cash Flow n/a -1.5M n/a -2.6K 5.61M 14.12M 24.49M -12.24M -27.27M n/a
Debt Repayment -280.92K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a -133.59K n/a n/a n/a n/a n/a
Other Financial Acitivies n/a n/a 28.3M 17.69M -417.88K n/a n/a n/a 400K n/a
Financial Cash Flow 6.64M 1.99M 28.3M 17.69M 3.58M 118.01K 2.63K 22.1K 80.84M n/a
Net Cash Flow -6.21M -17.11M 18.1M 7.38M -2.39M -9.36M -3.23M -44.27M 32.83M n/a
Free Cash Flow -12.85M -19.1M -10.2M -10.31M -11.58M -23.6M -27.84M -32.61M -21.01M n/a